Epidemiological Studies (Confidentiality) Regulations 2018

The instrument operates as a declaratory and schedule-based regulation under the enabling Act. Several core concepts and structural features govern its operation.

• Prescribed study link. The operative legal device is the declaration in Regulation 6 that certain Commonwealth epidemiological studies are “studies to which the Act applies” for the purposes of paragraph (b) of the definition of “prescribed study” in subsection 3(1) of the Act. The instrument therefore functions by reference to the Act’s definitional framework rather than by reproducing or varying the Act’s substantive provisions (Regulation 6).

• Formal definitions and cross-reference. The instrument defines the shorthand “Act” as meaning the Epidemiological Studies (Confidentiality) Act 1981 (Regulation 5). It also contains a note that “a number of expressions used in this instrument are defined in the Act,” signalling that interpretation of key terms for operational effect must be done by reference to the Act (Regulation 5, note).

• Specificity of declarations. Regulation 6 lists individual Commonwealth epidemiological studies with specific subject matter, conducting Commonwealth bodies and commencement years. Each listed item is phrased as “the Commonwealth epidemiological study in relation to [subject], conducted by [agency], being the study that commenced in [year],” or equivalent language (Regulation 6(a)-(l)). That form ties prescription to particular studies as described, rather than to a general subject area or an open-ended class.

• Commencement mechanics. The instrument contains a commencement table (Regulation 2). The whole instrument commences the day after registration, noted in the table as 30 March 2018. The instrument also includes the standard device that the table relates only to the instrument as originally made, and that material in the third column of the table is not part of the instrument (Regulation 2(1)-(2)).

• Schedules and repeal. Regulation 4 provides that each instrument specified in a Schedule is amended or repealed as set out in that Schedule. Schedule 1 contains a single item: repeal of the whole of the Epidemiological Studies (Confidentiality) Regulations 1982 (Schedule 1).

• Delegation of substantive content to the Act. While the instrument identifies which studies are “prescribed” (for the paragraph (b) limb of the Act’s definition), it does not restate the Act’s protections or enforcement provisions. Those substantive rules remain located in the Act itself; the instrument’s primary conceptual role is matching particular studies to the Act’s definition.

Together these concepts show that the instrument is a mapping exercise from named Commonwealth studies to the Act’s statutory regime. The narrow, descriptive drafting of each declared study means that identification of coverage requires comparison of real-world study projects to the instrument’s textual descriptions.

The instrument’s direct textual effect is to bring a defined set of Commonwealth epidemiological studies within the scope of the Epidemiological Studies (Confidentiality) Act 1981 (Regulation 6). The instrument therefore primarily affects the following parties as identified within its text and structure.

• The specified study populations. The instrument names subject groups for the declared studies by reference to the studies’ scopes. Examples include persons employed in relation to the United Kingdom Atomic Weapons Test Programme between specified dates (Regulation 6(a) and (k)); persons affected by the Atomic Weapons Test Programme (Regulation 6(k)); persons who have been charged in a Western Australian court with an offence relating to illicit drug use (Regulation 6(i)); intravenous drug users in relation to HIV (Regulation 6(j)); persons surveyed about motivations for illicit cocaine use or heroin distribution and other drug-related cohorts (Regulation 6(c)-(h), (e)-(f)); and persons in high-income groups evaluated for cocaine usage (Regulation 6(g)).

• Commonwealth agencies and named conducting bodies. The instrument lists the Commonwealth bodies that conducted or conducted the studies, and those agencies appear in the descriptions. These include the Department of Veterans’ Affairs (Regulation 6(k)), the National Health and Medical Research Council (Regulation 6(b)), the Research into Drug Abuse Program of the National Campaign Against Drug Abuse and its units (Regulation 6(c)-(h), (i)), and the Australian Customs Service (Regulation 6(l)). The named conducting bodies are the entities referenced in the instrument; those agencies and their successors would be the parties responsible for managing study records and for implementing measures that arise from the Act’s application once a study is prescribed (Regulation 6).

• Researchers, data custodians and administrators. Because the instrument declares specific studies to be ones “to which the Act applies,” persons who hold, process, administer, or are otherwise custodians of study data for the listed projects will be affected by the Act’s provisions as they apply to those studies. The instrument itself does not define custodial duties, but the declared inclusion of those studies signals that the Act’s confidentiality regime governs handling of their data (Regulation 6).

• Individuals seeking access to study information and third parties. Any person or entity that might, under normal circumstances, seek access to information generated by the studies (researchers, legal practitioners, public agencies, family members of study participants) will be affected to the extent the Act imposes restrictions or exemptions on disclosure for prescribed studies. The instrument does not itself set those access rules, but it places the listed studies within the Act’s regime that controls access and confidentiality (Regulation 6; see Regulation 5 note that definitions are in the Act).

• Legal advisers, compliance officers and forensic practitioners. Entities advising on records management, disclosure obligations, litigation discovery, or freedom of information queries will need to treat the listed studies as falling within the Act’s definition of “prescribed study” for the paragraph (b) limb, and advise clients accordingly. The instrument’s precise textual descriptions mean that determining whether a particular dataset or paper falls within the list requires comparison to the wording used in Regulation 6.

• Historical cohorts and veterans’ groups. The listing of studies related to the Atomic Weapons Test Programme (Regulation 6(a), (k)) means cohorts with historical exposure or employment history within those programmes are explicitly identified in the instrument; the instrument therefore affects how records concerning those cohorts are treated under the Act as declared studies.

The instrument does not state operational directions to non-Commonwealth parties, nor does it create new categories of private legal persons. Its textual reach is the set of studies named in Regulation 6 and the consequences of their being prescribed are those defined by the Act. Decision-making about exemptions, disclosures, enforcement and penalties is a matter for the Act, not this instrument, although the instrument determines which studies are governed by that Act.

The instrument itself does not set out duties, rights, offences or penalties. Its operative legal effect is declaratory: it declares specific studies to be “studies to which the Act applies” for the purposes of paragraph (b) of the definition of “prescribed study” in subsection 3(1) of the Act (Regulation 6). Therefore the specific duties and rights that apply to those declared studies are those contained in the Act, not in this instrument. The text of the instrument identifies the point of attachment to the Act but leaves the substantive regime to the Act itself.

For practical legal analysis, the following are the relevant article-level mechanics within the instrument that determine how duties and rights attach.

• Triggering of the Act’s provisions. By declaring a study to be a study to which the Act applies, the instrument triggers application of the Act’s provisions to the study named. The instrument does this expressly and exclusively via Regulation 6. Accordingly, any duties (for example confidentiality obligations, disclosure restrictions, or record-keeping requirements) and any rights (for example participant protections or privileges) that the Act confers in relation to “prescribed studies” will apply to the listed studies to the extent the Act defines them for paragraph (b) of the definition in subsection 3(1).

• Reliance on Act definitions. Regulation 5 defines “Act” as the Epidemiological Studies (Confidentiality) Act 1981 and contains a note that a number of expressions used in the instrument are defined in the Act. Therefore, to discover the substantive content of a duty or right that is triggered by the instrument, one must refer to the Act’s definitions, including subsection 3(1) where “prescribed study” is defined and where paragraph (b) is located.

• Specificity of study descriptions as a determinative factor. Because each declared study is described by subject matter, conducting body and commencement date in Regulation 6, the set of duties and rights imported from the Act attach only to those studies as described. If parties seek to apply the Act to other studies, they cannot rely on this instrument to do so unless those other studies fit the descriptions in Regulation 6 or are otherwise prescribed through the Act’s mechanisms.

• Administrative effect on conducting bodies. The instrument names conducting bodies for most of the declared studies (for example, the National Health and Medical Research Council for the AIDS-related study that commenced in 1983, and the Department of Veterans’ Affairs for the study commencing in July 2000) (Regulation 6(b), (k)). Those entities are the ones identified in the instrument as associated with the declared studies. Any administrative duties under the Act that fall upon conducting bodies in relation to prescribed studies will therefore be relevant to the named agencies, as a textual matter.

• No new statutory powers or penalties added by the instrument. The instrument contains no provisions that create additional powers, exemptions, penalties, or enforcement mechanisms beyond what the Act provides. Schedule 1 repeals the 1982 Regulations, so any procedural or administrative features previously in those regulations (if any existed) have been removed and replaced by this instrument; the instrument does not itself recreate administrative detail.

To determine the precise duties and rights that apply to each declared study, including disclosure permissions and restrictions, offences and potential penalties for breaches of confidentiality, and processes for authorised access, it is necessary to consult the relevant provisions of the Act. The instrument’s role is to identify which studies are caught by the Act; the substance of obligations and entitlements remains in the parent Act.

The instrument contains no provisions creating offences, penalties, or detailed enforcement mechanisms. It is an enabling and declaratory regulation whose purpose is to identify studies that fall within the Act’s definition of “prescribed study” for the paragraph (b) limb of subsection 3(1). Enforcement and penalty questions are therefore matters for the Act itself.

Relevant textual points in the instrument:

• No penalties in this instrument. The instrument’s substantive section (Regulation 6) and other provisions do not specify any fines, imprisonment terms, administrative penalties, or enforcement procedures. The instrument neither expands nor reduces statutory penalties; it simply designates studies for coverage under the Act.

• Authority clause points to the Act. Regulation 3 states that the instrument is made under the Epidemiological Studies (Confidentiality) Act 1981. That establishes that enforcement and penalty regimes applicable to “prescribed studies” are those set out in the Act, not in this instrument (Regulation 3).

• Repeal of prior regulations. Schedule 1 repeals the Epidemiological Studies (Confidentiality) Regulations 1982 in whole. If the 1982 Regulations previously contained procedural or enforcement detail that assisted in operationalising the Act for prescribed studies, that material is now removed by the Schedule. Any replacement procedural detail, enforcement guidance or administrative practice would need to be found in the Act or in other instruments or administrative policy. The instrument itself does not supply procedural enforcement detail.

• Administrative practice. Because the instrument names conducting bodies (Regulation 6), practical enforcement and compliance actions, such as internal investigations, responses to access requests, and internal disciplinary measures for breaches of confidentiality, will fall to the relevant conducting bodies and to Commonwealth authorities that the Act authorises to act. The instrument does not identify which agency administers the Act or which official enforces it; that allocation of enforcement responsibility resides in the Act.

• Implication for third parties. Persons seeking to compel disclosure of information generated by the listed studies (for example through litigation discovery, subpoenas or administrative subpoenas) must take the instrument into account because it declares the studies to be subject to the Act. Whether a disclosure is prohibited, permitted, or subject to an exception depends on the Act. The instrument itself is silent on how competing legal processes are to be reconciled.

In short, the instrument creates no penalties or enforcement procedures itself; it assigns a set of studies to the Act and thereby makes penalties and enforcement questions dependent on the Act’s text. Practitioners dealing with potential breaches, compelled disclosure, or enforcement should therefore consult the Act for the definitions of offences, penalty scales, and enforcement routes that apply once a study is prescribed by this instrument.

This instrument operates as a regulation made under the Epidemiological Studies (Confidentiality) Act 1981, and its interaction with other laws is therefore mediated primarily through that statutory relationship and through its Schedule repealing the prior regulations. The instrument’s text identifies a number of direct interaction points.

• Enabling Act as primary legal anchor. Regulation 3 expressly states that the instrument is made under the Act. The instrument’s substantive function is to bring particular studies within the Act’s scope (Regulation 6). Consequently, the instrument interacts with other laws to the same extent as the Act does, because it merely map-lists studies to which the Act will apply. Any conflicts, exemptions, or cross‑statutory interactions between the confidentiality rules of the Act and other Commonwealth laws are therefore governed by the Act’s own provisions, not this instrument.

• Repeal of the 1982 Regulations. Schedule 1 repeals the Epidemiological Studies (Confidentiality) Regulations 1982 in whole. That repeal removes the prior regulatory instrument as a source of rules about which studies are prescribed or about any procedural matters previously contained in that instrument. Any legal or administrative relationships that depended on the 1982 Regulations will now be determined by the Act together with this instrument and any other subsequent instruments or policies (Schedule 1).

• Cross-references to definitions contained in the Act. Regulation 5 contains a note that “a number of expressions used in this instrument are defined in the Act.” That creates a textual dependency: interpreting key terms in the instrument requires reference to the Act’s definitions. This means that the instrument interacts with the Act’s definitional rules, which in turn may interact with other statute definitions where the Act cross‑refers to other Commonwealth laws.

• Interaction with administrative and agency responsibilities. The instrument identifies agencies or administrative units that conducted the studies, for example the National Health and Medical Research Council and the Department of Veterans’ Affairs (Regulation 6). Any duties imposed on those agencies by other laws (for example record-keeping obligations under other Commonwealth statutes) will interact with their obligations under the Act once the studies are prescribed. The instrument does not resolve conflicts between obligations under the Act and obligations under other statutes; those conflicts are to be resolved by legal analysis of the Act and the other statutes.

• No express interaction with state or territory laws. The instrument lists studies that may involve persons located in states and territories (for example studies of persons charged in Western Australia). The instrument itself does not purport to displace or vary state or territory laws. Whether the Act and therefore the instrument’s declarations are inconsistent with or prevail over state laws will turn on federal constitutional and statutory principles contained in the Act, not on this instrument’s text.

• Administrative effect on disclosure in legal processes. Because the instrument declares certain studies to be subject to the Act, it will affect how documents and information from those studies are treated in statutory and judicial processes, insofar as the Act provides confidentiality, privilege or disclosure limits. The instrument itself does not specify how process rules (for example subpoenas, discovery obligations, or Freedom of Information requests) interact with the Act; that analysis derives from the Act.

In summary, the instrument interacts with other laws by functioning as the map that brings particular study datasets within the reach of the Act. The precise inter-statutory effects, including any precedence, inconsistency resolution, or procedural interplay, depend on the Act’s provisions and on the other statutes at issue.

The instrument contains limited historical material, and the only amendments recorded on the face of the instrument are the repeal of the prior 1982 Regulations and the commencement particulars for this instrument as originally made.

• Date and making authorities. The instrument is dated 29 March 2018 and records the Governor‑General and the Minister for Health as the authorities on the face of the instrument. The tabular commencement material records commencement as 30 March 2018, described as “the day after this instrument is registered” (Regulation 2(1), table).

• Repeal of the 1982 Regulations. Schedule 1 contains a single item repealing the whole of the Epidemiological Studies (Confidentiality) Regulations 1982 (Schedule 1). That is the only express repeal or amendment of other instruments recorded in the Schedule.

• Original-making provenance. Regulation 2 contains standard notes that the commencement table relates only to the provisions of this instrument as originally made, and that it will not be amended to deal with later amendments of the instrument. Regulation 2(2) further states that any information in column 3 of the table is not part of the instrument and may be edited in published versions (Regulation 2(2)). Those are standard drafting devices that reflect the instrument’s original-making provenance and the limits on the table’s legal effect.

• No further amendments recorded in the text. The instrument as supplied does not contain any subsequent amending items, transitional provisions or sunset clauses. The only Schedule action is the complete repeal of the prior 1982 Regulations. The instrument does not itself provide a mechanism for amendment beyond normal legislative or regulatory amendment processes under the Act.

• Effect on prior regulatory regime. By repealing the 1982 Regulations, the instrument extinguishes the prior regulatory list or procedural materials that the 1982 Regulations may have contained. Any regulatory features previously located in the 1982 Regulations are no longer operative and, unless replaced by this instrument or another instrument, their practical effect ceases.

• Implication for archival records. Because the instrument lists studies with commencement years that range from 1952 through the early 2000s (Regulation 6(a)-(l)), the instrument functions as a contemporary declaration in 2018 that those historical studies are to be treated as prescribed. The instrument therefore alters the present statutory status of historical datasets by bringing them explicitly within the Act’s scope as of its commencement date, but the instrument does not itself state whether any retrospective effect is intended beyond the Act’s ordinary operation.

Practitioners wanting a complete legislative lineage should note that the instrument replaces the 1982 Regulations in whole (Schedule 1), and should consult official registers for any later amendments after the instrument’s original making; the instrument’s text itself limits the table to original-making details (Regulation 2(1)).

The instrument’s text does not record any litigation history. It names no judicial decisions and cites no cases. The Schedule repeals the prior 1982 Regulations but contains no transitional litigation-related provisions.

Because this is a regulation that declares particular studies to be governed by the Act, litigation arising from the instrument would typically concern interpretation and application of the Act to the named studies, or disputes over whether particular data fall within the declared descriptions. None of those matters is narrated or recorded in the instrument itself.

Practical points from the instrument about potential litigation issues that are visible from the text:

• No cases named. The instrument does not name any case law or judicial decisions. Consequently, any argument about how courts have interpreted the Act or the effect of similar declarations must be grounded in case law external to this instrument and in the Act; that material is not provided within this instrument.

• Declaratory nature creates potential for legal challenge focused on classification. Because the instrument identifies studies by descriptive wording (subject, conducting body, commencement date), disputes in litigation could arise over whether a contested dataset or project falls within a Regulation 6 description. The instrument itself provides the textual benchmark for such a dispute. The instrument does not supply criteria beyond the textual descriptions, so litigation would focus on textual matching, factual history of the study, and the Act’s interpretation.

• No procedural appeals set out in the instrument. The instrument is silent as to any administrative appeal routes or review mechanisms specific to the regulation. Any legal challenges to an agency decision under the Act, or claims that the instrument should or should not apply to a particular dataset, will be governed by the Act and by general administrative law remedies; the instrument contains no bespoke litigation or review regime.

In short, the instrument contains no litigation record on its face. Any litigation history relevant to the operation of the instrument must be sought in external sources: judicial decisions applying the Act to the studies named or to similar circumstances, which are not contained in this text.

This instrument’s brevity and its reliance on the Act create several practical issues that practitioners should note. Each “gotcha” below is grounded in the instrument’s text and structure.

• Declaratory wording is tightly factual. Each declared study is specified by subject matter, conducting body and commencement year (Regulation 6). If a dataset, report or follow-up project differs from the instrument’s textual particulars (for example, different start date, a different conducting body, or a derivative project that post‑dates the commencement year), it may fall outside the instrument’s declaratory coverage. Do not assume that a project with a similar name or subject is captured unless it fits the instrument’s wording exactly.

• The instrument only addresses paragraph (b) of the definition of “prescribed study” in subsection 3(1) of the Act. Regulation 6 is explicit that the declarations are “for the purposes of paragraph (b) of the definition of prescribed study in subsection 3(1) of the Act.” That means the instrument is not purporting to exhaustively prescribe studies under every limb of the Act’s definition. Reliance on this instrument alone to determine whether a study is “prescribed” across all definitions in the Act can therefore be misleading.

• Definitions are in the Act. Regulation 5 contains a note that a number of expressions used in the instrument are defined in the Act. Consequently, terms such as “prescribed study,” “conducted by,” or any statutory classifications must be read against the Act’s definitions. The instrument’s text is not self-contained; misreading a term in the instrument without reference to the Act’s definition is a potential pitfall.

• Repeal of the 1982 Regulations may have removed procedural detail. Schedule 1 repeals the 1982 Regulations (Schedule 1). If the 1982 Regulations previously contained procedural instructions, exemptions or transitional arrangements relied upon by agencies or third parties, those provisions are extinguished by the repeal. Practitioners should not assume that old procedural practice survives unless it is reproduced in the Act or in other instruments or administrative guidance.

• Commencement table caveats. Regulation 2 contains two drafting notes: the commencement table relates only to this instrument as originally made and will not be amended to deal with later amendments; and the third column of the table is not part of the instrument (Regulation 2(1)-(2)). For historical or interpretive uses, the table’s material may be informative, but legally the instrument’s operative commencement is “the day after registration” as described.

• Agency attribution is descriptive, not prescriptive of custodianship. The instrument’s descriptions identify the conducting bodies for the studies (Regulation 6). The text does not, however, expressly designate custodianship, record ownership, or practical administrative responsibility for archived data. Do not assume that a named conducting body in Regulation 6 necessarily remains the records custodian; custodial arrangements may have changed and custody for legal purposes will be determined by the Act and by administrative fact.

• Narrow population descriptions. Some study descriptions use narrow population markers, for example persons charged in a Western Australian court with an offence relating to the use of illicit drugs (Regulation 6(i)). That narrow wording means that related datasets capturing other classes (for example persons arrested but not charged, or persons charged in other jurisdictions) may not be covered by the declaration.

• Historical scope may generate evidentiary disputes. Several declared studies relate to events and cohorts with historical dates going back to the 1950s (Regulation 6(a), (k)). Locating, identifying and matching historical records to the instrument’s descriptions can generate factual disputes. The instrument provides a textual baseline; parties should anticipate evidentiary contests about whether particular records belong to a declared study.

• No guidance on derivative research or data linkage. The instrument declares specific studies. It does not state whether derivative research using those datasets, secondary analysis, or linkage to other datasets is automatically captured. Whether such activities are within the Act’s protective ambit depends on the Act’s definitions and on how “study data” is defined in the Act; that determination cannot be made from this instrument alone.

These are not novel issues; they flow directly from the instrument’s form as a tight, descriptive declaration that attaches studies to the Act without restating the Act’s substantive rules or creating procedural detail.

Because the instrument itself does not set out duties or procedures, compliance requires a two-stage approach: (1) identifying whether a dataset or project matches the instrument’s textual descriptions; and (2) applying the Act’s substantive provisions to that identified study. The instrument provides the textual benchmark for stage (1) in Regulation 6 and defines “Act” in Regulation 5. Below are practical, source‑grounded steps for parties (administrators, researchers, agency legal teams) with potential compliance obligations.

1. Confirm whether your dataset or project is one of the declared studies in Regulation 6.

   • Compare the project’s subject matter, the conducting body, and the commencement year against the instrument’s wording for items (a)-(l). Regulation 6 identifies each declared study by these elements. If your project does not match those textual particulars exactly, do not assume coverage.

2. Where there is textual ambiguity, compile contemporaneous documentation.

   • For historical studies or projects that evolved over time, compile evidence of the project’s title, start date, conducting agency and scope. The instrument’s declarations are descriptive; factual proof will be required to show that particular records are part of a listed study.

3. Consult the Act for substantive obligations and rights.

   • Regulation 3 states the instrument is made under the Act and Regulation 5 notes definitions are in the Act. The specific confidentiality obligations, permitted disclosures, exceptions, offences and any authorised processes are set out in the Act. Legal advice should be sought to interpret how the Act applies to the declared study once a dataset is matched textually.

4. Update internal registers and records-management systems.

   • For agencies and conducting bodies named in Regulation 6 (for example the National Health and Medical Research Council, Department of Veterans’ Affairs, Australian Customs Service, and units within the Research into Drug Abuse Program), flag the listed studies in internal registers as being subject to the Act as of the instrument’s commencement. Treat records associated with the declared studies as subject to the Act pending detailed legal analysis under the Act.

5. Review and, if necessary, amend disclosure and access procedures.

   • Because Regulation 6 places the listed studies within the Act’s ambit, administrative procedures governing access requests, disclosure in litigation, freedom of information requests and research approvals should be reviewed against the Act’s requirements. The instrument does not specify those procedures, so alignment should be to the Act.

6. Note the repeal of the 1982 Regulations.

   • Schedule 1 repeals the prior regulations. If your compliance systems referenced the 1982 Regulations, update policies and retrain staff to rely on the Act and on this instrument’s list for identifying prescribed studies. Do not rely on repealed regulatory text.

7. Treat derivative projects and data linkages cautiously.

   • The instrument declares specific studies; it does not explicitly address whether derivative datasets or linkages are included. Until legal certainty is obtained from the Act (or authoritative guidance), treat secondary uses of data from the listed studies as potentially subject to the Act and seek legal advice.

8. Preserve chain-of-custody and provenance metadata.

   • Given the potential for evidentiary disputes about whether particular records belong to the declared studies, preserve provenance metadata (dates, project codes, authorising documents, data transfer logs) to demonstrate lineage if required.

9. Seek formal advice when third-party access is requested.

   • For subpoenas, discovery demands, or administrative requests affecting data from a declared study, obtain legal advice referencing both Regulation 6 and the relevant Act provisions before responding. The instrument itself does not authorise disclosure.

10. Record and document the decision-making process.

• Where practical, document the internal process used to determine whether a dataset falls within Regulation 6, including the textual comparison and the legal interpretation under the Act. That contemporaneous documentation will assist in responding to future queries or disputes.

These steps follow from the instrument’s text which: (a) identifies studies to be treated under the Act (Regulation 6), (b) defines “Act” as the controlling statutory source (Regulation 5), (c) establishes commencement (Regulation 2), and (d) repeals the prior regulations (Schedule 1). Compliance is therefore a function of correct textual matching to Regulation 6 and then correct application of the Act’s substantive rules.